
|Articles|November 14, 2018
Ways to Reduce Sample Size In Clinical Trials
Author(s)Company Press Release
Advertisement
Clinical trial costs have surged over the past decade, with recent reports stating that from 2008 to 2013, the average cost per patient increased by $23,600, or by 157%. A major contributor to the cost of a clinical trial is subject recruitment and the associated staff costs. So, examining every opportunity to reduce the sample size for a study is an important and necessary step in drug development. Reducing sample size without losing power can be accomplished by one of three principles. In this infographic, Statsols examines these and present 15 ways researchers can reduce sample size in clinical trials. Check out the infographic
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
2
ACT Brief: FDA CRL Transparency Pause, Protocol-Centric Recruitment Model Shift, and Medical Affairs Integration in Development
3
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
4
Bringing the Voice of Clinical Practice and Patients into Drug Development
5




